Article metrics

Download PDFPDF

769 CAR T cells undergoing epigenetic reprogramming by low-dose decitabine enhances persistent anti-tumor efficacy in vivo

 

Online download statistics by month:

Online download statistics by month: November 2020 to January 2024

AbstractFullPdf
Nov 2020164037
Dec 202040010
Jan 20213209
Feb 202140011
Mar 202156010
Apr 202174010
May 2021404
Jun 20210030
Jul 20210047
Aug 20210023
Sep 20210011
Oct 202128024
Nov 202150021
Dec 20213006
Jan 20222400
Feb 20222203
Mar 20222602
Apr 20227205
May 20224004
Jun 20222603
Jul 20221401
Aug 20222003
Sep 20221404
Oct 2022603
Nov 202226012
Dec 20222603
Jan 20232204
Feb 20233202
Mar 20231400
Apr 20231401
May 2023802
Jun 20232405
Jul 20232005
Aug 20232803
Sep 20232203
Oct 20233402
Nov 20233603
Dec 20233202
Jan 20242002
Total11400330